Urokinase-type plasminogen activator and its inhibitor PAI-1 in breast cancer: studies at both protein and mRNA level.
Reilly
D
D
Education and Research Centre, St. Vincent's Hospital, Dublin, Ireland.
Andreasen
P
P
Duffy
M J
MJ
D001943:Breast Neoplasms / Q000201:enzymology* / Q000235:genetics; D004792:Enzyme Precursors / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D009693:Nucleic Acid Hybridization; D010960:Plasminogen Activators / Q000032:analysis* / Q000235:genetics; D015849:Plasminogen Inactivators / Q000032:analysis* / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis* / Q000235:genetics
D004792:Enzyme Precursors; D015849:Plasminogen Inactivators; D012333:RNA, Messenger; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator